Labopharm Inc.
16Patents
4Active
16Granted
39Portfolio score
Filing activity: Mar 25, 1993 → Sep 16, 2008 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6338859B1 | Polymeric micelle compositions | Emerging Cross-Sectional Technologies | 83 | Expired |
| US6939564B2 | Water-soluble stabilized self-assembled polyelectrolytes | Chemistry; Metallurgy | 42 | Expired |
| US7018655B2 | Amphiphilic diblock, triblock and star-block copolymers and their pharmaceutical compositions | Chemistry; Metallurgy | 42 | Expired |
| US5456921A | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds | Human Necessities | 36 | Expired |
| US6780324B2 | Preparation of sterile stabilized nanodispersions | Human Necessities | 32 | Expired |
| US5603956A | Cross-linked enzymatically controlled drug release | Human Necessities | 31 | Expired |
| US7094810B2 | pH-sensitive block copolymers for pharmaceutical compositions | Human Necessities | 29 | Expired |
| US6780428B2 | Unimolecular polymeric micelles with an ionizable inner core | Performing Operations; Transporting | 26 | Expired |
| US5616343A | Cross-linked amylose as a binder/disintegrant in tablets | Human Necessities | 24 | Expired |
| US7510731B2 | Water-soluble stabilized self-assembled polyelectrolytes | Chemistry; Metallurgy | 23 | Active |
| US5885615A | Pharmaceutical controlled release tablets containing a carrier made of cross-linked amylose and hydroxypropylmethylcellulose | Human Necessities | 14 | Expired |
| US6419957B1 | Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents | Human Necessities | 14 | Expired |
| US7829120B2 | Trazodone composition for once a day administration | Human Necessities | 7 | Active |
| US7838600B2 | Process for the preparation of amphiphilic poly(N-vinyl-2-pyrrolidone) block copolymers | Chemistry; Metallurgy | 4 | Active |
| US7262253B2 | Process for the preparation of amphiphilic poly (N-vinyl-2-pyrrolidone) block copolymers | Chemistry; Metallurgy | 4 | Expired |
| US7988998B2 | Sustained-release tramadol formulations with 24-hour efficacy | Human Necessities | 4 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.